share_log

HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $33 Price Target

Benzinga ·  Mar 19 10:29

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $33 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 383

Recommended

Write a comment